Recall Register

Device recall: AbbVie PEG Kit 20 FR

Class II FDA enforcement event 75794. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

AbbVie is issuing an urgent field correction notification due to an increased number of reports of disconnections of the AbbVie 20FR PEG tube from the Y-connectors.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

AbbVie Inc. started this device recall on 22 Nov 2016. The firm address in the FDA record is in North Chicago, IL. FDA put the recall in Class II. FDA event 75794 has 1 product record. The first FDA enforcement report date is 28 Dec 2016. The record gives the status Terminated, with the termination date 9 Jul 2019.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

U.S. consignees located throughout the country and Puerto Rico. Foreign Consignees: Worldwide.

Recalling firm

AbbVie Inc., North Chicago, IL.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 75794: product records
Recall numberProductQuantityClassStatusReport date
Z-0786-2017AbbVie PEG Kit 20 FR541 unitsClass IITerminated28 Dec 2016

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2016
1,232
Share of these events in Class II
91%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
12

Other events of the firm

Other FDA enforcement events of AbbVie Inc.
InitiatedProduct (first record)TypeClassRecords
18 May 2026PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie coDrugClass III1
16 Sep 2024Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, DistributDrugClass II2
17 Oct 2023Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 6DrugClass III1
22 Jan 2018Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North Chicago, IL 60064, USADrugClass III1
8 Sep 2017AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pumpDrugClass III2
27 Apr 2017AbbVie PEG, PEG Kit 20FR, FOR ENTERAL USE ONLY, STERILE, Rx Only.DeviceClass II3
13 Jan 2017Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7 cassettes per carton, Rx OnlDrugClass II1
24 Mar 2016Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-DrugClass III1
15 Sep 2014CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbViDrugClass II1
10 Mar 2014Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringDrugClass II5

AbbVie Inc.: all 12 events

Official channels

Cite this page

Recall Register. FDA enforcement event 75794. https://recallregister.com/fda/ii/75794/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: U.S. consignees located throughout the country and Puerto Rico. Foreign Consignees: Worldwide.
What quantity of product is in FDA event 75794?
The FDA record gives this quantity: 541 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2016 have the same class?
91% of the 1,232 device events that started in 2016 are in Class II.